Biosimilars and the extrapolation of indications for inflammatory conditions

Overview of attention for article published in Biologics: Targets & Therapy, February 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#21 of 274)
High Attention Score compared to outputs of the same age (88th percentile)

Mentioned by

news: 1 news outlet
twitter: 8 X users

facebook: 1 Facebook page
googleplus: 1 Google+ user

Citations

dimensions_citation: 55 Dimensions

Readers on

mendeley: 71 Mendeley

Summary News X Facebook Google+ Dimensions citations

So far, Altmetric has seen 2 news stories from 1 outlets.

S3 Episode 5: New on the Market: Why Use Psoriatic Arthritis Biosimilars?

Medscape, 27 Jun 2023

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple…

S3 Episode 5: New on the Market: Why Use Psoriatic Arthritis Biosimilars?

Medscape, 22 Jun 2023

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple…